Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

Pediatric patients with prior SARS-CoV-2 infection had a higher risk of adverse postacute kidney outcomes, such as new-onset ...

The following is a summary of “Effect of pre-existing coronavirus antibodies on SARS-CoV-2 infection outcomes in exposed ...

Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have ...

Long COVID or post COVID-19 syndrome, is a clinical entity observed in certain patients wherein symptoms of illness persist ...

Newton-Wellesley Hospital said five staff members who had worked on its fifth floor were diagnosed with brain tumors — none ...

The following is a summary of “Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab,” published in the April 2025 issue of Journal of ...

SARS-CoV-2 infection also was associated with an increased risk of composite kidney events for kids and adolescents with ...

New research links multisystem inflammatory syndrome in children with COVID-19 to Epstein-Barr virus reactivation, revealing ...

A new study by researchers at George Washington University has found that certain bacteria living in the nose may influence ...

Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical ...

A new study reveals evidence that immune cells, liver cells and viral leftovers created a dangerous combination.